Glaukos
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
GKOS Key Statistics
Stock Snapshot
Glaukos(GKOS) stock is priced at $133.42, giving the company a market capitalization of 7.84B. It carries a P/E multiple of -40.56.
On 2026-05-11, Glaukos(GKOS) stock moved within a range of $130.04 to $135.26. With shares now at $133.42, the stock is trading +2.6% above its intraday low and -1.4% below the session's peak.
Trading activity shows a volume of 308.79K, compared to an average daily volume of 1.02M.
Over the past 52 weeks, Glaukos(GKOS) stock has traded between a high of $146.75 and a low of $73.16.
Over the past 52 weeks, Glaukos(GKOS) stock has traded between a high of $146.75 and a low of $73.16.
GKOS News
In late April 2026, Glaukos Corporation reported first‑quarter 2026 sales of US$150.57 million, a rise from US$106.66 million a year earlier, alongside a net lo...
Glaukos (GKOS) is back in focus after raising its 2026 net sales guidance to a range of US$620 million to US$635 million and reporting first quarter sales of US...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst ratings
93%
of 14 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.